The effect of Helicobacter pylori eardication on the fate of gastric hyperplastic polyp: a randomized controlled trial.

The effect of Helicobacter pylori eradication on the fate of gastric hyperplastic polyps

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000041258

Enrollment

Unknown

Registered

2020-12-23

Start date

2021-01-01

Completion date

Unknown

Last updated

2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric hyperplastic polyp

Interventions

experimental group:Hp eradication

control group:No treatment

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Aged 18-70 years, gastric hyperplastic polyp confirmed by endoscopy and pathology; hp active infection.

Exclusion criteria

Exclusion criteria: Previous proton pump inhibitor therapy within 4 weeks of the study; previous gastric surgery, previous H. pylori eradication,contraindication for H. pylori eradication,preganacy or lactation.

Design outcomes

Primary

Measure	Time frame
The size of gastric hyperplastic polyp;	—

Countries

China

Contacts

Public ContactNingning Dong

Beijing Friendship Hospital, Capital Medical University

dongnn83@163.com+86 15210609987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026